Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression

被引:135
作者
Wysk, M
Yang, DD
Lu, HT
Flavell, RA
Davis, RJ
机构
[1] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA
[2] Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Program Mol Med, Worcester, MA 01605 USA
[3] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Dept Med, Immunobiol Sect, New Haven, CT 06510 USA
关键词
D O I
10.1073/pnas.96.7.3763
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The p38 mitogen-activated protein kinase is activated by treatment of cells with cytokines and by exposure to environmental stress. The effects of these stimuli on p38 MAP kinase are mediated by the MAP kinase kinases (MKKs) MKK3, MKK4, and MKK6, We have examined the function of the p38 MAP kinase signaling pathway by investigating the effect of targeted disruption of the Mkk3 gene. Here we report that Mkk3 gene disruption caused a selective defect in the response of fibroblasts to the proinflammatory cytokine tumor necrosis factor, including reduced p38 MAP kinase activation and cytokine expression. These data demonstrate that the MKK3 protein kinase is a critical component of a tumor necrosis factor-stimulated signaling pathway that causes increased expression of inflammatory cytokines.
引用
收藏
页码:3763 / 3768
页数:6
相关论文
共 55 条
[1]   The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor [J].
Beyaert, R ;
Cuenda, A ;
VandenBerghe, W ;
Plaisance, S ;
Lee, JC ;
Haegeman, G ;
Cohen, P ;
Fiers, W .
EMBO JOURNAL, 1996, 15 (08) :1914-1923
[2]   Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059 -: SB 203580 also inhibits thromboxane synthase [J].
Börsch-Haubold, AG ;
Pasquet, S ;
Watson, SP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) :28766-28772
[3]   Engineering protein kinases with distinct nucleotide specificities and inhibitor sensitivities by mutation of a single amino acid [J].
Cohen, P ;
Goedert, M .
CHEMISTRY & BIOLOGY, 1998, 5 (07) :R161-R164
[4]   SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1 [J].
CUENDA, A ;
ROUSE, J ;
DOZA, YN ;
MEIER, R ;
COHEN, P ;
GALLAGHER, TF ;
YOUNG, PR ;
LEE, JC .
FEBS LETTERS, 1995, 364 (02) :229-233
[5]   Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); Comparison of the specificities of SAPK3 and SAPK2 (RK/p38) [J].
Cuenda, A ;
Cohen, P ;
BueeScherrer, V ;
Goedert, M .
EMBO JOURNAL, 1997, 16 (02) :295-305
[6]   INDEPENDENT HUMAN MAP KINASE SIGNAL-TRANSDUCTION PATHWAYS DEFINED BY MEK AND MKK ISOFORMS [J].
DERIJARD, B ;
RAINGEAUD, J ;
BARRETT, T ;
WU, IH ;
HAN, JH ;
ULEVITCH, RJ ;
DAVIS, RJ .
SCIENCE, 1995, 267 (5198) :682-685
[7]   Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6 [J].
Enslen, H ;
Raingeaud, J ;
Davis, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) :1741-1748
[8]   Conversion of SB 203580-insensitive MBP kinase family members to drug-sensitive forms by a single amino-acid substitution [J].
Eyers, PA ;
Craxton, M ;
Morrice, N ;
Cohen, P ;
Goedert, M .
CHEMISTRY & BIOLOGY, 1998, 5 (06) :321-328
[9]   INTERLEUKIN-1 ACTIVATES A NOVEL PROTEIN-KINASE CASCADE THAT RESULTS IN THE PHOSPHORYLATION OF HSP27 [J].
FRESHNEY, NW ;
RAWLINSON, L ;
GUESDON, F ;
JONES, E ;
COWLEY, S ;
HSUAN, J ;
SAKLATVALA, J .
CELL, 1994, 78 (06) :1039-1049
[10]   MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates [J].
Fukunaga, R ;
Hunter, T .
EMBO JOURNAL, 1997, 16 (08) :1921-1933